Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + LMB Chemo in Pediatric High-Risk B-NHL
NCT01516580Phase 3Completed
- Sponsor
- Gustave Roussy
- Start
- Dec 2011
- Primary completion
- Jun 2017
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of rituximab in B-cell non-Hodgkin lymphoma, B cell acute lymphoblastic leukemia (B-ALL), sponsored by Gustave Roussy. Started Dec 2011; status: completed.
02
Drugs
rituximab
03
Conditions
B-cell non-Hodgkin lymphomaB cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT01516580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516580.